Search For "mild to moderate cases of covid 19"
Ayush ministry transfers Ayush-64 drug technology to 46 companies
Updated : 4 years, 6 months ago IST
New Delhi [India], November 19 (ANI): The Central Council for Research in Ayurvedic Sciences (CCRAS) on Friday transferred the technology of Ayush-64, an effective drug treating in mild and asymptomatic and mild to moderate cases of Covid-19, to 46 companies, informed the Ministry of AYUSH.
Read More
Sun Pharma launches Favipiravir in India for Rs 35 per tablet
Updated : 5 years, 9 months ago IST
Mumbai (Maharashtra) [India], Aug 4 (ANI): Sun Pharmaceutical Industries said on Tuesday it has launched Favipiravir (200 mg) in India under the brand FluGuard at an economical price of Rs 35 per tablet for the treatment of mild to moderate cases of COVID-19.
Read More
Anti-viral drug favipiravir gets DGCI nod for 'restricted emergency use' i
Updated : 5 years, 11 months ago IST
New Delhi [India], June 19 (ANI): The Drug Controller General of India (DCGI) has granted permission to anti-viral drug favipiravir for "restricted emergency use" in mild to moderate cases of COVID-19, a senior government official confirmed to ANI.
Read More